004720.KS
PharmGen Science, Inc.
KSC · Healthcare · Drug Manufacturers - General · KR
KRW 3,140.00
−0.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.49x
- Price / sales
- 0.39x
- Price / cash flow
- 3.98x
Enterprise value
- Enterprise value
- KRW 49.6B
- EV / sales
- 0.28x
- EV / EBITDA
- 5.77x
- EV / EBIT
- 12.72x
- Market cap
- KRW 68.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026